Spizhenko Clinic
Spizhenko Clinic
Ucraina, Kiev
| Ucraina | Turchia | Austria | |
| Trapianto di midollo osseo allogenico da donatore non correlato | da $80,000 | da $80,000 | da $180,000 |
| Trapianto di midollo osseo allogenico da donatore consanguineo | da $45,000 | da $65,000 | da $150,000 |
| Trapianto di midollo osseo | da $45,000 | da $36,000 | da $140,000 |
| Trapianto autologo di midollo osseo | da $25,000 | da $31,500 | da $50,000 |
| Terapia con cellule CAR-T | da $150,000 | da $150,000 | da $350,000 |
Bookimed non aggiunge costi extra ai prezzi dei trattamenti di Linfoma. Le tariffe provengono dai listini ufficiali delle cliniche. Pagherai direttamente in clinica al tuo arrivo nel paese.
Bookimed si impegna per la tua sicurezza. Lavoriamo solo con strutture che mantengono elevati standard internazionali nei trattamenti di Linfoma e hanno le licenze necessarie per servire pazienti internazionali in tutto il mondo.
Bookimed offre assistenza esperta gratuita. Un coordinatore medico personale ti supporta prima, durante e dopo il trattamento, risolvendo qualsiasi problema. Non sarai mai solo nel tuo percorso di trattamento per Linfoma.
Lymphoma treatment in Ukraine is clinically safe but carries operational risks due to the conflict. Private centers like Spizhenko Clinic follow international NCCN protocols and serve global patients. Facilities in Kyiv use autonomous generators to maintain power stability. Medical staff maintain high standards for complex procedures.
Bookimed Expert Insight: Ukraine remains a strong option for patients needing high-volume expertise at a lower cost. Spizhenko Clinic illustrates this with 70,000 cases and specialized oncology focus. While clinical quality is high, logistics are the primary hurdle today. Patients often choose Kyiv or Lviv as these cities offer more stable services. Check if your clinic provides autonomous power before booking your stay.
Patient Consensus: Patients value the high expertise of local oncologists but often worry about treatment continuity during power outages. Many travelers now suggest securing medical evacuation insurance and verifying the current supply of specific medications before arrival.
Ukrainian specialized centers treat over 36 lymphoma subtypes according to international NCCN protocols. Medical facilities manage Hodgkin lymphoma and nearly all mature B-cell neoplasms. Patients can access advanced care including CAR T-cell therapy and allogeneic bone marrow transplantation in centers across Kyiv and other cities.
Bookimed Expert Insight: While many local centers focus on chemotherapy, Spizhenko Clinic serves over 70,000 patients using strict NCCN international protocols. This standardization ensures Ukrainian treatment matches global benchmarks. Large volumes at such facilities often result in higher diagnostic accuracy for rare subtypes like T-cell lymphomas.
Patient Consensus: Patients emphasize the need to verify specific drug availability through local support groups before starting treatment. Many recommend getting a second-opinion pathology report from European labs to confirm the exact lymphoma subtype.
Lymphoma diagnosis in Ukraine requires a physical exam and specialized testing to confirm the subtype. Patients undergo detailed blood work and imaging to stage the disease. Diagnostic accuracy depends on bone marrow biopsies and pathology reports following international oncology protocols like NCCN guidelines.
Bookimed Expert Insight: Kyiv centers like Spizhenko Clinic follow NCCN protocols and have served over 70,000 patients. Our data shows these facilities often group baseline blood tests and imaging into complex oncology diagnostic packages. This structure helps patients complete the necessary 2-week staging window faster than at rural centers.
Patient Consensus: Patients emphasize securing a full pathology report and PET-CT scan before starting any therapy. They note that getting a second opinion at major city clinics helps prevent misdiagnosis.
Lymphoma treatment in Ukraine typically involves 3 to 7 inpatient days for initial chemotherapy cycles. Stable patients often transition to outpatient care for subsequent rounds. Outpatient visits for infusions usually last 4 to 8 hours. These sessions include pre-medication and monitoring.
Bookimed Expert Insight: Ukraine remains a major hub for hematology with over 6,270 requests served. Clinics like Spizhenko Clinic follow international NCCN protocols and serve thousands of global patients. Our data shows that high-volume centers often optimize stays by using portable chemo pumps. This can successfully shift a 5-day inpatient stay into an outpatient home-monitored recovery.
Patient Consensus: Patients note that first sessions are always longer and recommend packing for a week. They emphasize that outpatient days are full-day commitments and suggest bringing essentials like chargers and snacks.
Lymphoma aftercare in Ukraine includes schedule-based monitoring after chemotherapy or bone marrow transplants. Follow-up typically focuses on blood counts and PET/CT imaging. Specialized oncology centers like Spizhenko Clinic follow NCCN international protocols. These protocols ensure long-term health monitoring and early detection of relapse.
Bookimed Expert Insight: Ukrainian clinics like Spizhenko Clinic serve over 70,000 patients with a focus on diagnosis. Our data shows follow-up care is often provided as separate, pay-as-you-go services. Patients should request a formal testing schedule at discharge. Local centers prioritize diagnostic precision over administrative logistics like transport.
Patient Consensus: Patients note that following up requires proactive self-management and booking. Many recommend arranging a local oncologist at home for continuous monitoring between visits.
Ukrainian oncology centers actively offer clinical trials and experimental therapies. The sector is recovering with a 64% increase in new trial launches. Major research hubs in Kyiv and Lviv remain functional. The Ministry of Health approves new studies in just 35 days.
Bookimed Expert Insight: Lymphoma patients can access experimental protocols at specialized centers like Spizhenko Clinic in Kyiv. This facility follows international NCCN protocols and manages full-cycle clinical trials. It serves over 70,000 patients, showing that local infrastructure remains robust for research. Patients should prioritize these established private centers for consistent trial coordination.
Patient Consensus: Patients mention it is important to verify trial availability through international registries first. Many note that for complex therapies like CAR-T, they often consider traveling to nearby Poland.